These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20065959)

  • 1. Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats.
    Lenard NR; Zheng H; Berthoud HR
    Int J Obes (Lond); 2010 Jun; 34(6):1001-10. PubMed ID: 20065959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu opioid receptor antagonism in the nucleus accumbens shell blocks consumption of a preferred sucrose solution in an anticipatory contrast paradigm.
    Katsuura Y; Taha SA
    Neuroscience; 2014 Mar; 261():144-52. PubMed ID: 24342569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens.
    Shin AC; Pistell PJ; Phifer CB; Berthoud HR
    Neuroscience; 2010 Oct; 170(2):580-8. PubMed ID: 20654704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
    Miner P; Shimonova L; Khaimov A; Borukhova Y; Ilyayeva E; Ranaldi R; Bodnar RJ
    Brain Res; 2012 Mar; 1443():34-51. PubMed ID: 22305145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats.
    Cole JL; Leventhal L; Pasternak GW; Bowen WD; Bodnar RJ
    Brain Res; 1995 Apr; 678(1-2):168-76. PubMed ID: 7620885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions.
    Bodnar RJ; Glass MJ; Ragnauth A; Cooper ML
    Brain Res; 1995 Nov; 700(1-2):205-12. PubMed ID: 8624711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic prevention of mu-opioid receptor (MOR) G-protein coupling in the pontine parabrachial nucleus persistently decreases consumption of standard but not palatable food.
    Ward HG; Simansky KJ
    Psychopharmacology (Berl); 2006 Sep; 187(4):435-46. PubMed ID: 16847679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gamma-Aminobutyric acid receptor subtype antagonists differentially alter opioid-induced feeding in the shell region of the nucleus accumbens in rats.
    Znamensky V; Echo JA; Lamonte N; Christian G; Ragnauth A; Bodnar RJ
    Brain Res; 2001 Jul; 906(1-2):84-91. PubMed ID: 11430864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nucleus accumbens adenosine-opioid interaction in mediating palatable food intake.
    Pritchett CE; Pardee AL; McGuirk SR; Will MJ
    Brain Res; 2010 Jan; 1306():85-92. PubMed ID: 19822132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitatory amino acid receptor subtype agonists induce feeding in the nucleus accumbens shell in rats: opioid antagonist actions and interactions with mu-opioid agonists.
    Echo JA; Lamonte N; Christian G; Znamensky V; Ackerman TF; Bodnar RJ
    Brain Res; 2001 Dec; 921(1-2):86-97. PubMed ID: 11720714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating.
    Giuliano C; Robbins TW; Nathan PJ; Bullmore ET; Everitt BJ
    Neuropsychopharmacology; 2012 Nov; 37(12):2643-52. PubMed ID: 22805601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice.
    Zuberi AR; Townsend L; Patterson L; Zheng H; Berthoud HR
    Eur J Pharmacol; 2008 May; 585(1):14-23. PubMed ID: 18396272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central amygdala opioid transmission is necessary for increased high-fat intake following 24-h food deprivation, but not following intra-accumbens opioid administration.
    Parker KE; Johns HW; Floros TG; Will MJ
    Behav Brain Res; 2014 Mar; 260():131-8. PubMed ID: 24257074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens.
    Schad CA; Justice JB; Holtzman SG
    J Neurochem; 1996 Dec; 67(6):2292-9. PubMed ID: 8931460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-fat intake induced by mu-opioid activation of the nucleus accumbens is inhibited by Y1R-blockade and MC3/4R- stimulation.
    Zheng H; Townsend RL; Shin AC; Patterson LM; Phifer CB; Berthoud HR
    Brain Res; 2010 Sep; 1350():131-8. PubMed ID: 20346352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens.
    Zhang M; Gosnell BA; Kelley AE
    J Pharmacol Exp Ther; 1998 May; 285(2):908-14. PubMed ID: 9580643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB1 receptors modulate the intake of a sweetened-fat diet in response to μ-opioid receptor stimulation of the nucleus accumbens.
    Skelly MJ; Guy EG; Howlett AC; Pratt WE
    Pharmacol Biochem Behav; 2010 Nov; 97(1):144-51. PubMed ID: 20562021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective mu- and kappa-opioid receptor antagonists administered into the nucleus accumbens interfere with rapid tolerance to ethanol in rats.
    Varaschin RK; Morato GS
    Psychopharmacology (Berl); 2009 Sep; 206(1):85-96. PubMed ID: 19506836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mu-Opioid receptor stimulation in the nucleus accumbens elevates fatty tastant intake by increasing palatability and suppressing satiety signals.
    Katsuura Y; Heckmann JA; Taha SA
    Am J Physiol Regul Integr Comp Physiol; 2011 Jul; 301(1):R244-54. PubMed ID: 21543633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions.
    Ragnauth A; Ruegg H; Bodnar RJ
    Brain Res; 1997 Aug; 767(1):8-16. PubMed ID: 9365010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.